These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2481782)

  • 1. Lack of inotropic effects of neuropeptide Y in human myocardium.
    Michel MC; Wirth SC; Zerkowski HR; Maisel AS; Motulsky HJ
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):919-22. PubMed ID: 2481782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte.
    Piper HM; Millar BC; McDermott BJ
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):333-7. PubMed ID: 2554154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
    Awad SJ; Einstein R; Potter EK; Richardson DP
    Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of neuropeptide Y (NPY) and 4-norleucine-NPY on isolated perfused rat hearts; effects of NPY on atrial and ventricular strips of rat heart and on rabbit heart mitochondria.
    Balasubramaniam A; Grupp I; Matlib MA; Benza R; Jackson RL; Fischer JE; Grupp G
    Regul Pept; 1988 Jun; 21(3-4):289-99. PubMed ID: 3413295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiadrenergic effect of neuropeptide Y on the ventricular cardiomyocyte.
    Millar BC; Piper HM; McDermott BJ
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):426-9. PubMed ID: 2854210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y prevents agonist-stimulated increases in contractility.
    Woo ND; Ganguly PK
    Hypertension; 1995 Sep; 26(3):480-4. PubMed ID: 7649585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of functional neuropeptide Y receptors in a human neuroblastoma cell line.
    Gordon EA; Kohout TA; Fishman PH
    J Neurochem; 1990 Aug; 55(2):506-13. PubMed ID: 2164571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
    Bell D; Millar BC; McDermott BJ
    Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y (18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventricular membranes.
    Balasubramaniam A; Sheriff S
    J Biol Chem; 1990 Sep; 265(25):14724-7. PubMed ID: 2168390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory and stimulatory effects of neuropeptide Y(17-36) on rat cardiac adenylate cyclase activity. Structure-function studies.
    Sheriff S; Balasubramaniam A
    J Biol Chem; 1992 Mar; 267(7):4680-5. PubMed ID: 1537851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria.
    Serone AP; Angus JA
    Br J Pharmacol; 1999 May; 127(2):383-90. PubMed ID: 10385237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenoreceptor-mediated effect of neuropeptide Y decreases cardiac inotropic responses.
    Woo ND; Lam DS; Hays JA; Panagia V; Ganguly PK
    Biochim Biophys Acta; 1994 Jul; 1222(3):457-63. PubMed ID: 8038215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacological investigation of the contribution of muscarinic receptor-linked potassium channels to the reversal by carbachol of positive inotropic responses of rabbit left atrium to cyclic AMP-generating agents.
    Ray A; MacLeod KM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1594-601. PubMed ID: 7690405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y inhibits cardiac adenylate cyclase through a pertussis toxin-sensitive G protein.
    Kassis S; Olasmaa M; Terenius L; Fishman PH
    J Biol Chem; 1987 Mar; 262(8):3429-31. PubMed ID: 3029113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NG-methyl-L-arginine decreases contractility, cGMP and cAMP in isoproterenol-stimulated rat hearts in vitro.
    Klabunde RE; Kimber ND; Kuk JE; Helgren MC; Förstermann U
    Eur J Pharmacol; 1992 Nov; 223(1):1-7. PubMed ID: 1335873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of neuropeptide Y and its analogues on inositol 1,4,5-trisphosphate level in rat cardiomyocytes.
    Xiang H; Brown JC
    Recept Channels; 1993; 1(4):315-21. PubMed ID: 8081728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process.
    Zhu J; Li W; Toews ML; Hexum TD
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1479-86. PubMed ID: 1335068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of neuropeptide Y (NPY) on isolated guinea-pig heart.
    Wahlestedt C; Wohlfart B; Håkanson R
    Acta Physiol Scand; 1987 Apr; 129(4):459-63. PubMed ID: 3591369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between neuropeptide Y and the adenylate cyclase pathway in rat mesenteric small arteries: role of membrane potential.
    Prieto D; Buus C; Mulvany MJ; Nilsson H
    J Physiol; 1997 Jul; 502 ( Pt 2)(Pt 2):281-92. PubMed ID: 9263910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.
    Franco-Cereceda A; Lundberg JM; Dahlöf C
    Acta Physiol Scand; 1985 Jul; 124(3):361-9. PubMed ID: 3840319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.